(BHR) Braemar Hotel Resorts - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US10482B1017

BHR: Hotels, Resorts, Luxury, Accommodations

Braemar Hotels & Resorts Inc. (NYSE: BHR) is a Maryland-based real estate investment trust (REIT) specializing in the ownership of luxury hotels and resorts. The company focuses on properties with high revenue per available room (RevPAR), targeting premium assets in desirable locations. Braemars portfolio is designed to capture strong cash flows from high-end hospitality markets.

As of the latest data, Braemar trades on the NYSE under the ticker symbol BHR. The company is classified under the Hotel & Resort REITs sub-industry within the GICS framework. Its average daily trading volume over the past 20 days is approximately 179,396 shares, with a last reported price of $2.84. The stocks short-term technical indicators show an SMA 20 of $2.66, SMA 50 of $2.76, and SMA 200 of $2.95, suggesting recent price fluctuations around these moving averages.

From a fundamental perspective, Braemar has a market capitalization of $199.91 million. The company currently reports a price-to-book (P/B) ratio of 0.62, indicating its stock is trading below its book value. The price-to-sales (P/S) ratio is 0.27, reflecting a low valuation relative to its revenue. However, the return on equity (RoE) is negative at -1.69%, signaling challenges in generating profits from shareholder equity.

3-Month Forecast: Based on the convergence of and , Braemar Hotels & Resorts Inc. is expected to experience moderate price volatility. The stocks SMA 20 and SMA 50 are currently below the SMA 200, indicating a potential bearish trend in the near term. However, the low average true range (ATR) of 0.13 suggests limited price movement, with resistance likely forming near the SMA 200 level of $2.95. On the fundamental side, the forward P/E of 21.28 implies market expectations for earnings growth, but the negative RoE and low P/S ratio may weigh on investor sentiment. Overall, the stock is projected to trade in a narrow range between $2.50 and $3.00 over the next quarter.

Additional Sources for BHR Stock

BHR Stock Overview

Market Cap in USD 231m
Sector Real Estate
Industry REIT - Hotel & Motel
GiC Sub-Industry Hotel & Resort REITs
IPO / Inception 2013-11-06

BHR Stock Ratings

Growth 5y 21.8%
Fundamental 7.25%
Dividend 58.0%
Rel. Strength Industry 50.3
Analysts 3/5
Fair Price Momentum 2.82 USD
Fair Price DCF 6.46 USD

BHR Dividends

Dividend Yield 12m 8.65%
Yield on Cost 5y 14.53%
Annual Growth 5y -12.68%
Payout Consistency 77.9%

BHR Growth Ratios

Growth Correlation 3m -33.6%
Growth Correlation 12m 43%
Growth Correlation 5y -20.7%
CAGR 5y 11.40%
CAGR/Max DD 5y 0.16
Sharpe Ratio 12m -0.07
Alpha 49.44
Beta 1.76
Volatility 43.95%
Current Volume 370.1k
Average Volume 20d 255.8k
What is the price of BHR stocks?
As of March 17, 2025, the stock is trading at USD 2.95 with a total of 370,112 shares traded.
Over the past week, the price has changed by -1.99%, over one month by +12.60%, over three months by -12.10% and over the past year by +65.06%.
Is Braemar Hotel Resorts a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Braemar Hotel Resorts is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 7.25 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BHR as of March 2025 is 2.82. This means that BHR is currently overvalued and has a potential downside of -4.41%.
Is BHR a buy, sell or hold?
Braemar Hotel Resorts has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold BHR.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for BHR stock price target?
According to ValueRays Forecast Model, BHR Braemar Hotel Resorts will be worth about 3.2 in March 2026. The stock is currently trading at 2.95. This means that the stock has a potential upside of +9.49%.
Issuer Forecast Upside
Wallstreet Target Price 3 1.7%
Analysts Target Price 3 1.7%
ValueRay Target Price 3.2 9.5%